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1Because life expectancy and the prevalence of risk fac-tors, such as hypertension, obesity, insulin resistance and 
diabetes mellitus are rising globally, heart failure is growing 
into a major health problem. Impairment of left ventricular 
diastolic function (LVDF) appears early in the course of heart 
disease. Recent heart failure guidelines, therefore, place spe-
cial emphasis on the detection of subclinical LV dysfunction 
and the timely identification of risk factors for progression to 
symptomatic heart failure.1 Conventional echocardiography 
combined with new imaging techniques such as tissue Doppler 
imaging (TDI) is a sensitive tool to detect early subclinical 
deterioration of LV function.2 Recent community-based stud-
ies revealed a higher than hitherto expected prevalence of 
LV diastolic dysfunction, using comprehensive conventional 
and TDI echocardiographic imaging.3–6 For instance, in the 
Flemish Study on Environment, Genes, and Health Outcomes 
(FLEMENGHO), the frequency was 27.3%.5 LV diastolic 
dysfunction is also associated with increased risk for various 
cardiovascular diseases.4,7,8
See Editorial by Fitzgibbons and Aurigemma
See Clinical Perspective
Community-based studies have identified cross-section-
ally that age, body mass index, heart rate (HR), and diastolic 
blood pressure (DBP) are important correlates of echocardio-
graphic LVDF indexes.5,6 However, data on the longitudinal 
tracking of LVDF over time are sparse. To our knowledge, 
2 community-based studies9,10 explored the factors predic-
tive of the development of subclinical LV diastolic dysfunc-
tion. In the clinical setting, Aljaroudi et al11 reported that in 
patients with normal baseline LV ejection fraction, worsen-
ing of diastolic function grade was an independent predictor 
of mortality. However, serial imaging studies are also needed 
to clarify the clinical correlates of change in LVDF indexes. 
These data are currently lacking. We, therefore, investigated 
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grade to more advanced grade (odds ratio, 3.22; P<0.0001). A doubling of baseline insulin was associated with a 184% 
increase in the odds of worsening of LVDF (P<0.0001). Moreover, baseline diastolic blood pressure and the change in 
systolic blood pressure over time predicted worsening of LVDF (P≤0.014).
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in the FLEMENGHO cohort clinical correlates of longitu-
dinal changes in Doppler diastolic indexes analyzed as con-
tinuous measures. We also assessed factors predictive of the 
changes in LVDF grades over time.
Methods
Study Participants
The Ethics Committee of the University of Leuven approved the 
FLEMENGHO study. From August 1985 until December 2005, we iden-
tified a random population sample stratified by sex and age from a geo-
graphically defined area in northern Belgium.5,12 Households, defined as 
those who lived at the same address, were the sampling unit. We numbered 
households consecutively, and generated a random number list by use of 
SAS random function. Households with a number matching the list were 
invited; household members aged >18 years were eligible. From 2005 to 
2009, we invited 1031 former participants for a re-examination at our field 
center, including echocardiography (Figure 1). All our participants at base-
line were ambulatory and physically apt to come to the examination center. 
We have to exclude 27 patients who were bed-ridden or institutionalized. 
We obtained informed written consent from 828 subjects (participation 
rate, 80%). To study the changes of LVDF, we invited these participants 
for a follow-up examination on average 5 years after their first echocar-
diographic examination. We excluded 147 participants because they died 
(n=25), were lost to follow-up (n=19) or declined invitation to participate 
in the echocardiographic examination (n=103) (Figure 1). For this analysis, 
we additionally excluded 16 subjects because of atrial fibrillation at base-
line (n=8) or at follow-up (n=6) or the presence of an artificial pacemaker 
(n=4), or because of diastolic function could not be reliably determined 
(n=13). Thus, the number of subjects statistically analyzed totaled 650.
Echocardiography
The participants refrained from smoking, heavy exercise, and drink-
ing alcohol or caffeine-containing beverages for at least 3 hours before 
echocardiography. The BP during echocardiography was the average of 
2 readings, obtained with a validated OMRON 705IT device (Omron 
Corp, Tokyo, Japan) at the end of the echocardiographic examination.
Data Acquisition
One experienced physician (T.K.) did both ultrasound examinations,5 
using a Vivid7 Pro and Vivid E9 (GE Vingmed, Horten, Norway), 
respectively, interfaced with a 2.5- to 3.5-MHz phased-array probe, 
according to the recommendations of the American Society of 
Echocardiography.13 With the subjects in partial left decubitus and 
breathing normally, the observer obtained images, together with a 
simultaneous ECG signal, along the parasternal long and short axes 
and from the apical 4- and 2-chamber long-axis views. All recordings 
included at least 5 cardiac cycles and were digitally stored for off-line 
analysis. M-mode echocardiograms of the LV were recorded from 
the parasternal long-axis view under control of the two-dimensional 
(2D) image. The ultrasound beam was positioned just below the mi-
tral valve at the level of the posterior chordae tendineae. To record 
pulsed wave Doppler transmitral and pulmonary vein (PV) flow ve-
locities from the apical window, the observer positioned a 1- to 3-mm 
Doppler sample volume at the mitral valve tips and in the right supe-
rior PV, respectively.
Using TDI, the observer recorded low-velocity, high-intensity 
myocardial signals at a high frame rate (>190 frames per second), 
while adjusting the imaging angle to ensure a parallel alignment of 
the ultrasound beam with the myocardial segment of interest. To re-
cord mitral annulus velocities, from the apical window, the sonogra-
pher placed a 5-mm Doppler sample at the septal, lateral, inferior, and 
posterior sites of the mitral annulus.
Off-Line Analysis
The postprocessing of echocardiograms was performed by an observ-
er (T.K.) blinded to the participants’ characteristics in a few weeks 
after the initial and follow-up examinations. Digitally stored images 
were analyzed using a workstation running the EchoPac software (GE 
Vingmed). All measurements were averaged >3 heart cycles for sta-
tistical analysis. The LV internal diameter and interventricular septal 
and posterior wall thickness were measured at end-diastole from the 
2D-guided M-mode tracing. When optimal orientation of M-mode 
ultrasound beam could not be obtained, the reader performed lin-
ear measurements on correctly oriented 2D images. End-diastolic 
LV dimensions were used to calculate LV mass by an anatomically 
validated formula according to the recommendations of the American 
Society of Echocardiography.13 We calculated LV ejection fraction 
from LV end-systolic and end-diastolic volumes measured from the 
apical 4 and 2 chambers views, using the standard Simpson method. 
We measured left atrial (LA) dimensions in 3 orthogonal planes, such 
as the parasternal long, lateral, and supero-inferior axes. LA volume 
index was calculated using the prolate-elipsoid method and was in-
dexed to body surface area.
From the transmitral flow signal, we measured peak early diastolic 
velocity (E), peak late diastolic velocity (A), the E/A ratio, and A 
flow duration. From the PV flow signal, we measured the duration of 
PV reversal time during atrial systole. From the TDI recordings, we 
measured peaks systolic (s′) and early (e′) and late (a′) diastolic mitral 
annular velocities, and the e′/a′ ratio at the 4 acquisition sites (septal, 
lateral, inferior, and posterior). We calculated the E/e′ ratio by divid-
ing transmitral E peak by e′ averaged from the 4 acquisition sites.
We combined the mitral inflow and TDI velocities to classify the 
stages of LV diastolic dysfunction at baseline and follow-up as previ-
ously described.5,6 The first group included subjects with an abnor-
mally low age-specific transmitral E/A ratio indicative of impaired 
relaxation, but without evidence of increased LV filling pressures 
(E/e′≤8.5). The second group had mild-to-moderate elevated LV fill-
ing pressure (E/e′>8.5), and E/A ratio within the normal age-specific 
range. We also used the differences in durations between the mitral A 
flow and the reverse PV flow during atrial systole (Ad<ARd+10) or 
LA volume index (≥29 mL/m2) to confirm possible elevation of the LV 
filling pressures in group 2. We reclassified ≈5% of subjects as having 
normal diastolic function, because, although their E/e′ was between 
8.5 and 10, other echocardiographic parameters, including PV flow 
and LA volume index were normal. Group 3 had an elevated E/e′ ratio 
and an abnormally low age-specific E/A ratio (combined dysfunction).
Intraobserver (T.K.) reproducibility coefficient of a measurement 
was the 2SD interval about the mean of the relative differences across 
pairwise readings. As reported previously,14 for conventional Doppler 
parameters, the reproducibility was 5.0% for transmitral E peak and 
FLEMENGHO Echocardiographic Substudy
Invited (n=1031)
Echocardiographic examination 1 
2005-2009 
(n=828)
Echocardiographic examination 2 
2009-2013 
(n=650)
Declined invitation (n=203)
LV diastolic function could not 
be determined at baseline 
(n=16) or at follow-up (n=15)
Lost-to-follow-up (n=19)
Died  (n=25)
Declined invitation (n=103)
Figure 1. Flowchart for participants in the study. FLEMENGHO 
indicates Flemish Study on Environment, Genes, and Health Out-
comes; and LV, left ventricular.
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6.6% for transmitral A peak. For tissue Doppler velocities, the repro-
ducibility across the 4 sampling sites ranged from 4.5% to 5.3% for e′ 
velocities and from 4.0% to 4.5% for a′ velocities.
Other Measurements
The conventional BP was the average of 5 consecutive auscul-
tatory readings obtained with the subject in the seated position. 
Hypertension was defined as a BP of at least 140 mm Hg systolic 
or 90 mm Hg diastolic or as the use of antihypertensive drugs. 
Body mass index was weight in kilograms divided by the square 
of height in meters. Venous blood samples were drawn for mea-
surement of blood glucose, serum insulin, and total cholesterol. 
Diabetes mellitus was determined by self-reported diagnosis, 
fasting glucose level of at least 126 mg/dL, or use of antidiabetic 
agents.
Table 1. Characteristics of Participants
Clinical Measurements Echocardiographic Measurements
Characteristic
Examination 1 
(2005–2009)
Examination 2 
(2009–2013) P Value Characteristic
Examination 1 
(2005–2009)
Examination 2 
(2009–2013) P Value
Anthropometrics Conventional echocardiography
  Age, y 50.7±14.6 55.5±14.5 <0.0001 LA volume index, 
mL/m2
23.0±6.13 25.8±6.76 <0.0001
  Body mass index, 
kg/m2
26.5±4.28 27.2±4.32 <0.0001 LV internal 
diameter, cm
5.05±0.45 5.02±0.43 0.02
  Systolic pressure, 
mm Hg
128.8±16.8 132.4±17.0 <0.0001 Interventricular 
septum, cm
0.98±0.16 1.01±0.16 <0.0001
  Diastolic 
pressure, mm Hg
79.8±9.3 82.3±9.8 <0.0001 Posterior wall, cm 0.89±0.14 0.95±0.12 <0.0001
  Mean arterial 
pressure, mm Hg
96.1±10.3 99.0±10.2 <0.0001 Relative wall 
thickness
0.37±0.06 0.39±0.05 <0.0001
  Pulse pressure, 
mm Hg
49.0±14.3 50.0±15.8 0.07 LV mass index, 
g/m2
92.2±21.0 95.8±21.4 <0.0001
  Heart rate, bpm 60.3±9.4 60.1±9.8 0.19 Ejection fraction, 
%
63.4±6.6 61.1±6.5 <0.0001
Questionnaire data Doppler data
  Current smoking, 
n (%)
123 (18.9) 98 (15.1) <0.0001 TDI s’ peak, cm/s* 9.07±1.42 8.02±1.34 <0.0001
  Drinking alcohol, 
n (%)
267 (41.0) 247 (37.9) 0.08 Transmitral E 
peak, cm/s
75.8±15.9 67.0±15.6 <0.0001
  Hypertensive, 
n (%)
268 (41.2) 333 (51.2) <0.0001 Transmitral A 
peak, cm/s
64.8±17.0 61.1±15.3 <0.0001
  Treated for 
hypertension, 
n (%)
160 (24.6) 209 (32.1) <0.0001 E/A ratio 1.26±0.47 1.18±0.46 <0.0001
   β-blockers, n (%) 98 (15.0) 113 (17.4) 0.03 TDI e′ peak, cm/s* 11.5±3.57 9.76±3.39 <0.0001
   ACE or ARB, n (%) 52 (8.0) 72 (11.1) 0.004 TDI a′ peak, cm/s* 10.2±2.07 9.56±2.14 <0.0001
   CCB or α-
blockers, n (%)
27 (4.1) 42 (6.5) 0.002 TDI e′/a′ ratio* 1.24±0.64 1.13±0.62 <0.0001
   Diuretics, n (%) 58 (8.9) 76 (11.7) 0.01 E/e′ ratio 7.07±2.14 7.44±2.52 <0.0001
  History of CHD, n (%) 18 (2.8) 31 (4.8) <0.0001 … … … …
  History of diabetes 
mellitus, n (%)
26 (4.0) 31 (4.8) 0.09 … … … …
Biochemical data …
  Serum creatinine, 
μmol/L
84.2±16.1 89.8±22.6 <0.0001 … … … …
  Total cholesterol, 
mmol/L
5.26±0.96 5.04±0.95 <0.0001 … … … …
  Insulin, μmol/L 4.79 (2.00–10.0) 5.25 (2.00–12.0) 0.0002 … … … …
Values are mean (±SD), number of subjects (%) or geometric mean (10%–90% percentile interval). ACE indicates angiotensin-converting 
enzyme; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; CHD, coronary heart disease; LA, left atrium; LV, left ventricle; 
and TDI, tissue Doppler imaging.
*Averaged of septum, lateral, inferior, and posterior mitral annulus sites.
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Statistical Methods
For database management and statistical analysis, we used SAS soft-
ware, version 9.3 (SAS Institute, Cary, NC). We compared changes in 
means and proportions by means of a paired t test and the McNemar 
tests, respectively. Statistical significance was a 2-sided significance 
level of 0.05.
We performed forward stepwise linear regression to determine 
clinical correlates of change in the Doppler diastolic indexes as mea-
sured on a continuous scale during a mean follow-up period of 4.7 
years. The baseline characteristics considered as covariables in linear 
regression were sex, age, body mass index, HR, systolic BP (SBP) 
and DBP, serum insulin, creatinine, and diabetes mellitus. These 
variables were chosen on the basis of their cross-sectional associa-
tion with LV Doppler diastolic indexes in the previously published 
reports5 and in this study (Tables I and II in the Data Supplement). We 
also included in models the changes in body mass index, HR, SBP, 
and DBP, and coding for antihypertensive drug intake (starting treat-
ment between baseline and follow-up or remaining on treatment). We 
set the P values for variables to enter and to stay in the regression 
models at 0.05.
We searched for variables associated with change in LV diastolic 
(dys-)function grading using stepwise logistic regression including 
the covariables mentioned above. In a sensitivity analysis, we used 
inverse probability weighting to adjust for possible selection bias 
caused by dropouts.
Results
Characteristics of Participants
Follow-up echocardiographic data were available in 650 par-
ticipants of whom 330 (50.8%) were women. At baseline, 
the mean age was 50.7 (SD, 14.6) years. The median fol-
low-up was 4.7 years (5th to 95th percentile, 3.7–5.4 years). 
Table 1 shows the clinical and echocardiographic character-
istics of the study participants by the examination phase. At 
the follow-up examination, the prevalence of hypertension 
increased from 41.2% (n=268) to 51.2% (n=333; P<0.0001). 
From examination 1 to 2, SBP, DBP, and mean BP increased 
by 3.60±13.6, 2.55±8.66, and 2.90±9.18 mm Hg, respec-
tively (P<0.0001 for all; Table 1). In contrast, pulse pressure 
(P=0.07) and HR (P=0.19) did not significantly change over 
time (Table 1). Body mass index increased slightly at exami-
nation 2 (+0.72±1.87 kg/m2; P<0.0001). We also observed 
significant changes in LA volume index and LV mass index, 
averaging 2.82 mL/m2 and 3.61 g/m2, respectively (Table 1).
Correlates of Changes in Diastolic Function Indexes
During follow-up, transmitral and TDI early and late dia-
stolic velocity significantly decreased (P<0.0001 for all; 
Table 1) although the magnitude of decrease was greater for 
early than late diastolic velocities (Figure 2). Subsequently, 
we observed that the E/A and e′/a′ ratios changed by −5.3% 
(−33.7% to 29.7%) and −8.0% (−38.2% to 28.7%), respec-
tively (P<0.0001 for all; Table 1; Figure 2), whereas E/e′ ratio 
increased by 6.1% (−20.0% to 38.1%; P<0.0001; Table 1; Fig-
ure 2). Figure 3 shows histograms of change over time in the 
diastolic Doppler velocities and their ratios.
Table 2 lists the correlates of the 4.7 years change in LVDF 
Doppler velocities and ratios. As expected, the significant 
correlate of change in any of LV diastolic index was baseline 
LV diastolic index, being inversely associated with ∆ LV dia-
stolic index (Table 2). We also observed that the magnitude 
of decrease in most of diastolic indexes was greater in men 
than in women (Table 2). Advanced age and higher baseline 
HR as well as an increased HR during follow-up were related 
to larger decreases in the transmitral E velocity, E/A and e′/a′ 
ratios during the follow-up period (Table 2). The decreases 
in the E/A and e′/a′ ratios during follow-up were also more 
pronounced in subjects with higher DBP at baseline and more 
increase in DBP during follow-up. Baseline HR and ∆ HR 
were associated with significant increase in the transmitral 
A and TDI a′ velocities (P<0.0001; Table 2). Longitudinal 
decrease in TDI e′ velocity was significantly correlated with 
baseline age, DBP, and serum insulin, and with ∆ body mass 
index and ∆ DBP over time (Table 2). An increase in E/e′ ratio 
over time was significantly correlated with higher baseline 
age, SBP, and serum insulin as well as with greater increases 
in body mass index and SBP during follow-up (Table 2). For 
the change in Doppler diastolic velocities and ratios, the range 
of the explained total variance by the covariates (Table 2) var-
ied between 11.2% and 36.5%.
Changes in LV Diastolic Dysfunction Grade and 
Factors Predictive of Worsening Diastolic Function 
Grade
During follow-up, the prevalence of LV diastolic dysfunction 
of any degree slightly increased from 23.5% (95% confidence 
interval [CI], 20.2%–26.8%) to 27.5% (95% CI, 24.1%–
30.9%; P<0.001). Within-subject changes in LVDF grade 
during 4.7 years were presented in Table 3. LVDF grades 
remained unchanged in 567 participants (87.2%; 95% CI, 
84.6%–89.8%), improved in 24 participants (3.7%; 95% CI, 
2.25%–5.15%), and worsened in 59 participants (9.1%; 95% 
CI, 6.9%–11.3%).
In multivariable stepwise logistic regression (Table 4), the 
risk of progressing from normal LVDF to impaired relaxation 
was directly associated with age at baseline (P<0.0001), HR 
at baseline (P=0.0008), and increase in HR during follow-up 
(P<0.0001). Moreover, we observed that subjects who started 
or remained on antihypertensive treatment more often pro-
gressed to impaired relaxation (P=0.005). Advanced age was 
a strong predictor of worsening of LVDF from ≤1 grade to 
grade ≥2 (odds ratio, 3.22; P<0.0001). We also found that a 
doubling of baseline insulin was associated with an ≈184% 
increase in risk of worsening of LVDF (P<0.0001). Moreover, 
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Figure 2. Mean within-subject changes (±SE) in left ventricular Dop-
pler diastolic function indexes during 4.7 years (P<0.0001 for all).
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baseline DBP and an increase in SBP over time predicted pro-
gression from grades ≤1 to grade ≥2. Risk estimates for a 10 
mm Hg increment in baseline DBP and in ∆ SBP were 102% 
and 47%, respectively (P≤0.014).
Table III in the Data Supplement lists characteristics of sub-
jects who did not return for examination 2. Non-participants 
had significantly higher baseline HR, serum insulin and 
prevalence of smokers than participants (Table III in the Data 
Supplement). The use of inverse probability weighting to 
adjust for possible bias caused by dropouts did not materially 
affect the factors predicting progression of LVDF (Table IV in 
the Data Supplement). Figure I in the Data Supplement showed 
examples of different patterns of LVDF changes as assessed by 
transmitral Doppler and mitral annular TDI velocities.
Discussion
Because of aging population and the increasing burden of dia-
stolic heart failure, it is important to understand determinants 
of LV diastolic dysfunction during the adult life course.15 
Serial imaging studies should clarify the progression of LV 
function changes. In this context, we evaluated in the general 
Figure 3. The histograms of change in left ventricular Doppler diastolic indexes in the entire population. The curves represent the fitted 
normal (full line) and Kernel (dotted line) density plots. TDI indicates tissue Doppler imaging.
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population clinical correlates of longitudinal changes in Dop-
pler diastolic indexes analyzed as continuous measures and 
assessed factors predictive of the worsening of LVDF grade 
over time. The key findings of this study are that LV diastolic 
dysfunction tended to worsen over time and was associated 
with advanced age, higher baseline insulin level, and hemody-
namic parameters, such as HR and BP.
The gold standard for assessing diastolic function remains 
the pressure-volume relationship, but this requires an invasive 
approach. Doppler measurements of mitral inflow and the TDI 
technique open up the possibility of evaluating noninvasively 
diastolic function.2,16 In our study, we assessed LVDF nonin-
vasively using the transmitral flow and the TDI mitral annu-
lar velocities. Previous studies validated these indexes versus 
invasive measures of diastolic function.2 LV diastolic dysfunc-
tion is defined as functional abnormalities that exist during LV 
relaxation and filling. Impaired myocardial relaxation is char-
acterized by decreased early (E peak), but enhanced atrial LV 
filling (A peak) as well as less vigorous mitral annulus motion 
during early diastole (TDI e′ peak). Moreover, e′ peak veloc-
ity along the LV longitudinal axis is less susceptible to the 
effects of an increased preload and, therefore, provides a more 
direct measure of myocardial relaxation than, for instance, the 
transmitral E peak velocity. In addition, combining transmi-
tral flow velocity with annular velocity (E/e′ ratio) might be a 
tool for assessing the LV filling pressure, which combines the 
influence of the transmitral driving pressure and myocardial 
relaxation.2
Table 2. Correlates of 4.7 Years Change in LVDF
Change in LVDF Indexes
Variables ∆ E (cm/s) ∆ A (cm/s) ∆ E/A ∆ e′ (cm/s) ∆ a′ (cm/s) ∆ e′/a′ ∆ E/e′
∆, mean (5%–95% CI) −8.84  
(−27.2 to 11.1)
−3.64  
(−19.3 to 10.6)
−0.084  
(−0.55 to 0.37)
−1.70  
(−4.45 to 0.60)
−0.60  
(−3.19 to 1.93)
−0.11  
(−0.57 to 0.32)
0.35  
(−1.61 to 2.51)
Adjusted R 2 29.8% 33.7% 36.5% 24.7% 35.7% 26.0% 11.2%
Partial regression coefficients (% of explained variances)
  Baseline LVDF 
index, +1 SD
−6.60±0.46‡ 
(15.3%)
−6.40±0.41‡ 
(20.6%)
−0.24±0.014‡ 
(11.5%)
−1.26±0.11‡ 
(10.7%)
−0.63±0.070‡ 
(9.4%)
−0.26±0.11‡ 
(9.6%)
−0.41±0.08‡ 
(3.1%)
  Years of follow-up, 
+1 y
−2.81±0.68‡ 
(1.9%)
−0.66±0.59 −0.034±0.016* 
(0.60%)
−0.43±0.10‡ 
(2.2%)
−0.24±0.084† 
(0.78%)
−0.0057±0.019 0.019±0.091
Baseline risk factors
  Age, +10 y −2.68±0.29‡ 
(6.2%)
2.06±0.27‡  
(3.4%)
−0.11±0.009‡ 
(10.1%)
−0.61±0.066‡ 
(7.4%)
… −0.072±0.011‡ 
(1.5%)
0.16±0.049†  
(1.5%)
  Men −4.29±0.83‡ 
(2.2%)
−2.04±0.62† 
(1.0%)
−0.036±0.018* 
(0.38%)
−0.24±0.11† 
(1.0%)
… −0.061±0.020‡ 
(1.8%)
…
  Heart rate,  
+10 bpm
−1.88±0.47‡ 
(1.8%)
1.25±0.37‡  
(1.7%)
−0.057±0.012‡ 
(2.1%)
… 0.38±0.006‡  
(3.6%)
−0.055±0.012‡ 
(1.8%)
…
  Body mass index, 
+1 kg/m2
… 0.31±0.08†  
(1.0%)
0.0065±0.0022† 
(0.72%)
… … … …
  SBP, +10 mm Hg … … … … … … 0.25±0.051† 
(0.82%)
  DBP, +10 mm Hg … … −0.050±0.011‡ 
(2.8%)
−0.23±0.073‡ 
(1.4%)
… −0.049±0.015† 
(0.87%)
−0.18±0.070* 
(0.96%)
  Serum insulin, per 
doubling
… … … −0.81±0.14* 
(0.70%)
… … 0.94±0.071‡  
(1.2%)
Change in risk factors
  ∆ Heart rate,  
+10 bpm
−3.43±0.53‡ 
(3.2%)
3.02±0.41‡  
(5.7%)
−0.12±0.012‡ 
(8.2%)
… 1.04±0.007‡ 
(21.9%)
−0.12±0.014‡ 
(9.3%)
−0.18±0.070† 
(1.2%)
  ∆ Body mass index, 
+1 kg/m2
… 0.46±0.16†  
(0.8%)
… −0.092±0.031‡ 
(1.5%)
… −0.012±0.0054† 
(1.0%)
0.11±0.030†  
(1.3%)
  ∆ SBP, +10 mm Hg … … … … … … 0.19±0.046‡  
(2.2%)
  ∆ DBP, +10 mm Hg … … −0.034±0.011† 
(1.0%)
−0.26±0.072* 
(0.73%)
… −0.039±0.013† 
(1.1%)
…
We performed stepwise multiple regression to assess the independent correlations of changes in LVDF indexes with baseline risk factors, such as sex, age, body 
mass index, heart rate, systolic and diastolic blood pressure, serum creatinine, insulin, and coding for antihypertensive drug intake (starting treatment between baseline 
and follow-up or remaining on treatment). We also included in stepwise models the changes in these risk factors. Values are mutually adjusted partial regression 
coefficients±SE. VIF were <2.50 for all explanatory variables with exception of VIF for age in relation to e′ (VIF=3.21) and the e′/a′ ratio (VIF=3.00). CI indicates 
confidence interval; DBP, diastolic blood pressure; LVDF, left ventricular diastolic function; SBP, systolic blood pressure; and VIF, variance inflation factors.
*P<0.05, significance of the partial regression coefficient.
†P<0.01, significance of the partial regression coefficient.
‡P<0.001, significance of the partial regression coefficient.
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In our previous reports,5,6 which were focused on the 
prevalence and comparison of echocardiographic criteria for 
LV diastolic dysfunction between European populations, we 
found that the age-standardized prevalence of LV diastolic 
dysfunction varied between 22.4% and 25.1%. Age-specific 
cut-off limits for the transmitral E/A ratio and the threshold 
for the E/e′ ratio, which we used for the classification of LV 
diastolic dysfunction, were consistent and reproducible across 
independently recruited population cohorts. The same also 
applied to the cross-sectional correlates of the conventional 
Doppler and TDI indexes. These observations lend support to 
our longitudinal epidemiological approach, which allowed us 
to understand the correlates of LVDF indexes as well as trace 
the natural history of LVDF in the participants with and with-
out LV diastolic dysfunction at baseline.
Age, body mass index, and hemodynamic factors, such as 
HR and DBP, were major determinants of LV Doppler dia-
stolic indexes in our previous cross-sectional study based on 
single-occasion measurements.5 In this analysis, we demon-
strated that these covariates were also significant correlates of 
tracking of LVDF indexes during a 4.7-year period. In addi-
tion, baseline LV Doppler diastolic indexes were significant 
predictors of change in diastolic indexes. To our knowledge, 
our study was the first to describe the correlates of longitudi-
nal changes in LV Doppler diastolic function indexes.
During follow-up, we observed a progression of LV diastolic 
dysfunction: 9.1% of participants showed worse diastolic 
function and 87.2% of participants had LVDF unchanged. 
Presently, only 1 population-based study9 described the pro-
gression of LV diastolic dysfunction in the general popula-
tion. Similar to our study, this study applied a comprehensive 
Doppler analysis to grade LV diastolic dysfunction in subjects 
aged ≥45 years.9 The authors reported more marked progres-
sion of diastolic dysfunction than in our study. Indeed, in 
the Kane et al’s9 study, 23.4% of participants showed worse 
LVDF grade. The difference between studies has to be inter-
preted, keeping in mind that in our study the mean age was 
50.7 years, whereas in the Olmsted cohort the mean age was 
61.0 years. In both the studies, the worsening of diastolic dys-
function increased with advanced age at baseline. Moreover, 
Table 3. Change in Diastolic Function Grades from 
Examination 1 to 2 in All Participants
Diastolic Function Groups, Examination 2
Diastolic 
Function Groups, 
Examination 1
Normal 
Function, 
Group 0
Impaired 
Relaxation, 
Group 1
Elevated 
LV Filling 
Pressure, 
Group 2
Combined 
Dysfunction, 
Group 3
Total 
(Exami- 
nation 
1)
Normal function, 
group 0
454* 33† 6† 4† 497  
(76.5%)
Impaired 
relaxation, 
group 1
16‡ 30* 8† 8† 62  
(9.5%)
Elevated LV filling 
pressure, group 2
1‡ 6‡ 55* 13† 75  
(11.5%)
Combined 
dysfunction,  
group 3
0‡ 1‡ 5 10* 16  
(2.5%)
Total  
(examination 2)
471  
(72.5%)
70  
(10.8%)
74  
(11.4%)
35  
(5.4%)
650 
(100%)
LV indicates left ventricle.
*No. of subjects with no change in LV diastolic function grade between 2 
examinations.
†Participants with worsening LV diastolic function.
‡Participants with improved grade.
Table 4. Factors Predictive of the Development or Worsening of Diastolic 
Dysfunction From Examination 1 to 2
Factor
Remains in the 
Same LVDF Grade
Change of  
LVDF Grade
Mutually Adjusted 
OR (95% CI) P Value
Development of LV diastolic dysfunction (normal LVDF→1)
  n 454 33
  Age, y 46.1±13.0 57.7±12.5 2.43 (1.61–3.71)* <0.0001
  Baseline heart rate, bpm 59.6±8.8 61.0±9.9 2.46 (1.49–4.05)* 0.0008
  Δ heart rate, bpm −0.40±7.49 4.76±7.24 4.81 (2.59–8.95)* <0.0001
  Start of AHT or remain on 
AHT, (1 vs 0)
65 (14.3%) 13 (39.4%) 3.32 (1.43–7.68) 0.005
Worsening of LV diastolic dysfunction (LVDF grade ≤1→≥2)
  n 533 26
  Age, y 47.4±13.4 61.2±10.8 3.22 (1.97–5.23)* <0.0001
  Baseline Insulin, μU/mL 3.98 (2.00–8.91) 7.41 (3.02–22.9) 2.84 (1.84–4.38)† <0.0001
  Baseline DBP, mm Hg 79.4±9.13 83.7±10.1 2.02 (1.20–3.39)* 0.008
  Δ SBP, mm Hg 3.41±12.3 7.92±20.1 1.47 (1.08–1.99)* 0.014
We performed stepwise logistic regression to assess the independent correlations of changes in LVDF 
grade with baseline risk factors and their changes as described in Table 2. AHT indicates antihypertensive 
therapy; CI, confidence interval; DBP, diastolic blood pressure; LVDF, left ventricular diastolic function; OR, 
odds ratio; and SBP, systolic blood pressure.
*OR are expressed per 10 units increase.
†Odds ratios is expressed for a doubling baseline insulin.
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the difference could also be explained by the fact that we used 
age-specific criteria for LVDF grading. It is probable that by 
applying the same threshold values for the Doppler indexes 
throughout the age range, we may overestimate the prevalence 
of mild subclinical diastolic dysfunction in older participants.
The HR determines the time that is available for ventricu-
lar relaxation, diastolic filling, and coronary perfusion. An 
increase in HR might affect the diastolic function by sev-
eral mechanisms: it decreases time of LV filling, and causes 
incomplete or impaired relaxation. Indeed, in our study we 
observed that higher baseline HR and ∆ HR during the follow-
up period was associated with the development of impaired 
relaxation. In line with our findings, Burns et al17 have shown 
that increased HR produced by atrial pacing results in signifi-
cant changes in conventional and tissue Doppler parameters 
of LVDF. The authors demonstrated that an increase in HR led 
to a significant reduction in the early mitral inflow velocity, an 
increase in A and a′ velocities.
In our previous cross-sectional study,5 we found that the 
prevalence of diastolic dysfunction increased with serum insu-
lin level. In this longitudinal analysis, we found that baseline 
insulin level was associated with the worsening of LV dia-
stolic dysfunction grade. Our findings are in line with previ-
ous data reporting association between glucose metabolism 
and LVDF.18,19 Moreover, recent longitudinal study in type 2 
diabetic patients implied that LV diastolic dysfunction dete-
riorates more in subjects with than in those without type 2 
diabetes mellitus.10 The biological pathways leading to the 
alterations of myocardial composition and, thus, of LV dia-
stolic properties in subjects with impaired insulin resistance 
and glucose metabolism might be mediated by changes in the 
coronary microcirculation.20 Microvascular damage may lead 
to myocardial cell injury and reactive fibrosis/hypertrophy.21
Our study has to be interpreted within the context of its 
potential limitations and strengths. First, the Doppler blood 
flow measurements and the TDI velocities are prone to mea-
surement error. In this study, 1 experienced observer recorded 
all Doppler images using a highly standardized imaging pro-
tocol. All digitally stored images were centrally postprocessed 
by a single observer at baseline and follow-up with a good 
reproducibility. Moreover, previous work of Hare et al22 sug-
gested that transmitral and tissue Doppler velocities were rea-
sonably reproducible in 346 consecutive patients undergoing 
sequential echocardiography. Second, patterns of transmitral 
flow and mitral annulus velocities also depend on the com-
pliance and contractile function of the LA. Thus, we did not 
evaluate LVDF in participants with sustained atrial fibrillation. 
Third, as in our study we included only white European popu-
lations, the generalizability of the findings to other ethnici-
ties is currently limited and should also be further explored by 
additional research.
In conclusion, LV diastolic dysfunction tended to worsen 
over time and was associated with advanced age, higher baseline 
insulin level and hemodynamic parameters, such as HR and BP.
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CLINICAL PERSPECTIVE
Because life expectancy and the prevalence of risk factors, such as hypertension, obesity, insulin resistance, and diabetes 
mellitus are rising globally, heart failure is growing into a major health problem. Impairment of left ventricular diastolic 
function seems early in the course of heart disease. Therefore, it is important to understand determinants of LV diastolic 
dysfunction during the adult life course. Serial imaging studies should clarify the progression of LV function changes. In 
this context, we evaluated in the general population clinical correlates of longitudinal changes in Doppler diastolic indexes 
analyzed as continuous measures and assessed factors predictive of the worsening of left ventricular diastolic function grade 
over time. In our previous cross-sectional study based on single-occasion measurements, age, body mass index, and hemo-
dynamic factors such as heart rate and diastolic blood pressure were major determinants of LV Doppler diastolic indexes. In 
this analysis, we demonstrated that these covariates were also significant correlates of tracking of left ventricular diastolic 
function indexes during a 4.7-year period. In addition, baseline LV Doppler diastolic indexes were significant predictors of 
change in diastolic indexes. Another key finding of this study was that LV diastolic dysfunction tended to worsen over time 
and was associated with advanced age, higher baseline insulin level, and hemodynamic parameters, such as heart rate and 
blood pressure.
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SUPPLEMENTAL Table S1.  Correlates of the E/A, e’/a’ and E/e’ ratios in stepwise regression by examination 
Parameter  Transmitral E peak (cm/s)  Transmitral A peak (cm/s)  Transmitral E/A 
 Examination 1 Examination 2  Examination 1 Examination 2  Examination 1 Examination 2 
Adjusted R² (%) 30.9 38.0  55.5 55.3  64.1  62.1  
Partial regression coefficients         
Female (0,1)                   
ß±SE  
Partial r2 (%) 
 
9.091.10‡ 
7.1 
 
9.481.00‡ 
7.7 
  
6.460.92‡ 
2.9 
 
6.010.82‡ 
3.6 
  
... 
 
... 
Age (+10 years) 
ß±SE  
Partial r2 (%) 
 
–4.970.42‡ 
13.8 
 
–5.730.40‡ 
19.5 
  
6.030.35‡ 
38.9 
 
5.430.32‡ 
37.1 
  
–0.220.009‡
48.5 
 
–0.220.008‡ 
46.7 
BMI (+1 kg/m2) 
ß±SE  
Partial r2 (%) 
 
… 
 
… 
  
0.740.11‡ 
3.6 
 
0.730.097‡ 
4.3 
  
–0.0140.003‡
2.7 
 
–0.0130.003‡ 
1.3 
HR (+10 beats/minute) 
ß±SE  
Partial r2 (%) 
 
–3.630.59‡ 
5.2  
 
–4.440.52‡ 
8.2 
  
3.710.49‡ 
8.4 
 
3.510.42‡ 
8.9 
  
–0.150.012‡
11.1 
 
–0.130.012‡ 
11.1 
SBP (+10 mm Hg) 
ß±SE  
Partial r2 (%) 
 
2.550.42‡ 
1.4 
 
1.800.37‡ 
0.76 
  
1.730.31‡ 
2.1 
 
1.420.28‡ 
1.8 
  
0.0280.009†
0.56 
 
... 
DBP (+ 10 mm Hg) 
ß±SE  
Partial r2 (%) 
 
–3.530.69‡ 
2.88 
 
–2.540.58‡ 
1.84 
  
... 
 
... 
  
–0.0770.015‡
1.1 
 
–0.0700.012‡ 
3.1 
Use of RAAS blockers 
ß±SE  
Partial r2 (%) 
 
–5.051.98* 
0.73 
 
…  
  
... 
 
... 
  
... 
 
... 
Use of β-blockers 
ß±SE  
Partial r2 (%) 
 
–3.441.55* 
0.52 
 
–3.761.37† 
0.71 
  
... 
 
... 
  
–0.110.033†
0.46 
 
... 
Values are mutually adjusted partial regression coefficients ±SE.  BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.  Significance of the partial 
regression coefficient: * P<0.05, †P<0.01, and ‡P<0.001. There were no differences between the partial regression coefficients in two studies.
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SUPPLEMENTAL Table S2.  Correlates of TDI e', e’/a', and E/e’ in stepwise regression by examination 
Parameter  TDI e' peak (cm/s)  TDI e'/a' peak  E/e' 
 Examination 
1 
Examination 2 Examination 
1 
Examination 2 Examination 1 Examination 2 
Adjusted R² (%) 73.7 71.8 72.7 66.9 45.6  43.7  
Partial regression coefficients       
Female (0,1)                   
ß±SE  
Partial r2 (%) 
 
… 
 
… 
  
0.0560.028* 
0.17 
 
0.100.029‡ 
0.63 
  
1.010.13‡ 
3.9 
 
1.030.15‡ 
3.2 
Age (+10 years) 
ß±SE  
Partial r2 (%) 
 
–1.810.058‡ 
63.5 
 
–1.750.052‡
62.5 
  
–0.340.011‡ 
58.9 
 
–0.300.0097‡ 
50.1 
  
0.570.049‡ 
32.0 
 
0.620.059‡ 
29.3 
BMI (+1 kg/m2) 
ß±SE  
Partial r2 (%) 
 
–0.170.018‡ 
7.0 
 
–0.130.018‡
5.7 
  
–0.0320.003‡
7.7 
 
–0.0250.003‡ 
2.9 
  
0.110.015‡ 
5.1 
 
0.120.018‡ 
3.4 
HR (+10 beats/minute) 
ß±SE  
Partial r2 (%) 
 
–0.270.080‡ 
0.44  
 
–0.300.075‡
0.54  
 
–0.110.015‡ 
3.3 
 
–0.150.015‡ 
8.2 
 
–0.220.069† 
0.89 
 
–0.210.079†
0.63 
SBP (+10 mm Hg) 
ß±SE  
Partial r2 (%) 
 
0.130.058* 
0.20 
 
… 
 
0.0500.010‡ 
0.96 
 
… 
 
0.320.043‡ 
4.2 
 
0.420.051‡ 
7.5 
DBP (+ 10 mm Hg) 
ß±SE  
Partial r2 (%) 
 
–0.690.095‡ 
2.5 
 
–0.570.076‡
2.9 
  
–0.140.018‡ 
2.0 
 
–0.110.015‡ 
5.4 
  
... 
 
... 
Use of RAAS blockers 
ß±SE  
Partial r2 (%) 
 
… 
 
… 
  
... 
 
... 
  
... 
 
... 
Use of β-blockers 
ß±SE  
Partial r2 (%) 
 
–0.820.22‡ 
0.36 
 
–0.550.20† 
0.32 
  
... 
 
... 
  
... 
 
... 
Values are mutually adjusted partial regression coefficients ±SE.  BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood 
pressure.  Significance of the partial regression coefficient: * P<0.05, †P<0.01, and ‡P<0.001. There were no differences between the partial regression coefficients 
in two studies. 
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SUPPLEMENTAL Table S3.   Characteristics of Participants and Non-participants 
                              Clinical Measurements   Echocardiographic Measurements   
Characteristic  Participants  
(n=650) 
Non-participants 
(n=137)  
P Characteristic  Participants  
(n=650) 
Non-participants 
(n=137)  
P 
Anthropometrics     Conventional echocardiography     
Age, y  50.714.6 48.4±18.1 0.16 LA volume index, ml/m²  23.0±6.13  21.9±6.55  0.07 
Body mass index, kg/m²  26.5±4.28 26.3±4.40 0.60 LV internal diameter, cm  5.05±0.45  5.01±0.53  0.39 
Systolic pressure, mm Hg   128.8±16.8 129.518.5 0.65 Interventricular septum, cm  0.98±0.16  0.97±0.17  0.46 
Diastolic pressure, mm Hg  79.8±9.3 79.310.1 0.62 Posterior wall, cm  0.89±0.14  0.90±0.15  0.49 
Mean arterial pressure, mm Hg   96.1±10.3 96.111.5 0.96 Relative wall thickness 0.370.06  0.38±0.07  0.57 
Pulse pressure, mm Hg  49.0±14.3 50.114.9 0.39 LV mass index, g/m²  92.2±21.0  92.3±24.8  0.95 
Heart rate, beats/minute  60.3±9.4 63.4±10.5 0.002 Ejection fraction, %  63.4±6.60  63.5±6.76  0.93 
Questionnaire data     Doppler data     
Current smoking, n (%)   123 (18.9) 38 (27.1) 0.03 TDI s' peak#, cm/s 9.071.42  9.11±1.59  0.78 
Drinking alcohol, n (%)   267 (41.0) 54 (38.6) 0.61 Transmitral E peak, cm/s 75.815.9  74.9±15.8  0.55 
Hypertensive, n (%)   268 (41.2) 53 (37.9) 0.48 Transmitral A peak, cm/s  64.8±17.0  63.5±19.1  0.43 
Treated for hypertension, n (%)   160 (24.6) 32 (22.9) 0.69 E/A ratio   1.26±0.47  1.31±0.54  0.27 
History of CHD, n (%) 18 (2.76) 3 (2.14) 0.68 TDI e' peak#, cm/s 11.53.57  11.7±4.00  0.55 
History of diabetes, n (%) 26 (3.99) 7 (5.00) 0.26 TDI a' peak#, cm/s 10.22.07  9.69±2.19 0.02 
Biochemical data     TDI e'/a' ratio# 1.240.64  1.35±0.73  0.10 
Serum creatinine, μmol/l  84.216.1 81.0±13.9 0.02 E/e' ratio 7.07±2.14  7.02±2.28  0.84 
Total cholesterol, mmol/l 5.260.96 5.151.03 0.20     
Insulin, µmol/l 4.79  
(2.00 to 10.0) 
5.01  
(2.00 to 14.5) 
0.02     
Values are mean (±SD), number of subjects (%) or geometric mean (10%–90% percentile interval). CHD, coronary heart disease; LV, left ventricle; LA, left atrium.  #Averaged of septum, lateral, 
inferior and posterior mitral annulus sites. 
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SUPPLEMENTAL Table S4.  Factors Predictive of the Development or 
Worsening of Diastolic Dysfunction From Examination 1 to Examination 2 with 
Correction for Drop-out Bias  
Factor Mutually adjusted  
OR (95% CI) 
P-value 
Development of LV diastolic dysfunction 
(Normal LVDF → 1) 
  
N    
Age, years 2.37 (1.48-3.71)a 0.0004 
Baseline heart rate, beats/min 2.59 (1.48-4.81)a 0.0007 
∆ heart rate, beats/min 4.05 (2.16-7.93)a <0.0001 
Start or remain on AHT, (1 vs 0) 3.00 (1.22-7.37) 0.017 
Worsening of LV diastolic dysfunction 
(LVDF grade ≤ 1 → ≥ 2) 
  
N    
Age, years  3.11 (1.97-5.23)a <0.0001 
Baseline Insulin, μU/ml   2.88 (2.01-4.13)b <0.0001 
Baseline DBP, mmHg 2.16 (1.34-3.39)a 0.001 
∆ SBP, mmHg 1.34 (1.00-1.97)a 0.050 
∆ heart rate, beats/min 0.60 (0.39-0.90)a 0.038 
 aOdds ratios (OR) are expressed per 10 unit increase.  bOdds ratios is expressed for a doubling 
baseline insulin. LVDF, left ventricular diastolic  dysfunction; AHT, antihypertensive therapy, DBP, 
diastolic blood pressure; SBP, systolic blood pressure.  
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Legend to Supplemental Figure S1 
Examples of different patterns of diastolic function as assessed by transmitral Doppler and mitral annular TDI 
velocities at baseline and follow-up.  E - early mitral inflow;  A - atrial mitral inflow; e’- early diastolic annular velocity; 
a’ - late diastolic annular velocity.   A. Unchanged pattern of LV diastolic function in 48-year old woman who had 
normal age-specific transmitral E/A ratio (from 2.5th to 97.5th percentiles of the reference subgroup) and no 
evidence of increased LV filling pressures (E/e’< 8.5) at baseline and follow-up.  B.  Development of LV diastolic 
dysfunction in 53-year old man with E/A ratio within the normal age-specific range at baseline and follow-up (from 
2.5th to 97.5th percentiles of the reference subgroup), but with an elevated E/e’ ratio (13.0) at follow-up because of 
a significant decrease of TDI e’. C.  Development of LV diastolic dysfunction in 63-year old woman who 
demonstrated at follow-up an abnormally low age-specific transmitral E/A ratio (0.57) indicative of impaired 
relaxation (less than 2.5th percentile of the reference subgroup) together with moderately elevated end-diastolic 
filling pressure with E/e’ =13.1. 
A.   
Unchanged 
pattern 
 
 
 
 
B. 
Development 
of LV diastolic 
dysfunction  
(N → group 2) 
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of LV diastolic 
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(N → group 3) 
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